---
title: RUNX1 loss renders hematopoietic and leukemic cells dependent on interleukin-3
  and sensitive to JAK inhibition
date: '2023-08-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37581927/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20230816180836&v=2.17.9.post6+86293ac
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Disease-initiating mutations in the transcription factor RUNX1 occur
  as germline and somatic events that cause leukemias with particularly poor prognosis.
  However, the role of RUNX1 in leukemogenesis is not fully understood and effective
  therapies for RUNX1-mutant leukemias remain elusive. Here, we use primary patient
  samples and a RUNX1 knockout model in primary human hematopoietic cells to investigate
  how RUNX1 loss contributes to leukemic progression and to identify ...
disable_comments: true
---
Disease-initiating mutations in the transcription factor RUNX1 occur as germline and somatic events that cause leukemias with particularly poor prognosis. However, the role of RUNX1 in leukemogenesis is not fully understood and effective therapies for RUNX1-mutant leukemias remain elusive. Here, we use primary patient samples and a RUNX1 knockout model in primary human hematopoietic cells to investigate how RUNX1 loss contributes to leukemic progression and to identify ...